BioPharma Dive - Biotech startups have not had an easy time in 2022. After record numbers of new biotech stock offerings in 2020 and 2021, a market downturn shut the door on
![Kochava Media Index - BioPharma Dive Advertising Mediakits, Reviews, Pricing, Traffic, Rate Card Cost Kochava Media Index - BioPharma Dive Advertising Mediakits, Reviews, Pricing, Traffic, Rate Card Cost](http://adimages.adbeat.com/f32c5e4363f49dbb2c98fc0c431351e1.jpg)
Kochava Media Index - BioPharma Dive Advertising Mediakits, Reviews, Pricing, Traffic, Rate Card Cost
![New database from BioPharma Dive designed to help you analyze the current boom in biotech IPOs – Benchworks New database from BioPharma Dive designed to help you analyze the current boom in biotech IPOs – Benchworks](https://benchworks.com/wp-content/uploads/2021/02/GettyImages-958668374-Converted-02.jpg)
New database from BioPharma Dive designed to help you analyze the current boom in biotech IPOs – Benchworks
![Bridging BioScience and BioBusiness, LLC - Biobusiness for Life-science Education for Professionals and Students Bridging BioScience and BioBusiness, LLC - Biobusiness for Life-science Education for Professionals and Students](http://bridgingbioscienceandbiobusiness.com/images/BBB_BioPharmaDive_Catalog.png)